Literature DB >> 21841324

Impaired glucose metabolism slows executive function independent of cerebral ischemic lesions in Japanese elderly: the Takahata study.

Yoshimi Takahashi1, Chifumi Iseki, Manabu Wada, Tadasuke Momma, Masao Ueki, Toru Kawanami, Makoto Daimon, Kyoko Suzuki, Gen Tamiya, Takeo Kato.   

Abstract

OBJECTIVE: Age is known to influence the risk of both cerebral ischemic lesions and impaired cognitive function. Diabetes mellitus (DM) can also be associated with cognitive impairment. However, there has been no study of neuropsychological performance in association with glucose metabolism status and cerebral ischemic lesions in same-aged, community-dwelling elderly persons. The present study was performed to clarify which cognitive domains are associated with impaired glucose metabolism/DM and whether the association is independent of cerebral ischemic lesions. SUBJECTS AND METHODS: A total of 172 residents in Takahata, Japan, all of whom were 78 years old, were evaluated in multiple domains through neuropsychological tests and brain MR images, as well as a medical check-up including tests for glucose metabolism status and conventional vascular risk factors. Glucose metabolism status was determined by analysis of HbA1c level.
RESULTS: In multiple regression analyses, performance on a verbal fluency (VF) test and the Trail Making Test-Part B, both of which represent executive function, was associated with HbA1c level, even after adjustment for sex, education, cerebral ischemic lesions, and conventional vascular risk factors. The subjects with DM also showed lower VF scores than did those without DM.
CONCLUSION: The results of the present study demonstrate that impaired glucose metabolism, independent of the conventional vascular risk factors and cerebral ischemic lesions, may be associated with a decline in executive function in community-dwelling elderly.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21841324     DOI: 10.2169/internalmedicine.50.4871

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Modeling metabolic syndrome and its association with cognition: the Northern Manhattan study.

Authors:  Bonnie E Levin; Maria M Llabre; Chuanhui Dong; Mitchell S V Elkind; Yaakov Stern; Tatjana Rundek; Ralph L Sacco; Clinton B Wright
Journal:  J Int Neuropsychol Soc       Date:  2014-11-10       Impact factor: 2.892

2.  Metabolic syndrome factors and risk of postoperative depression in high-grade glioma patients in a 1.5-year prospective study.

Authors:  Jian-Tong Jiao; Chen Jiang; Jin Huang; Min-Chao Dai; Cheng Wang; Chao Cheng; Jun-Fei Shao
Journal:  Med Oncol       Date:  2014-09-16       Impact factor: 3.064

3.  Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht Aging Study.

Authors:  Peggy J J Spauwen; Sebastian Köhler; Frans R J Verhey; Coen D A Stehouwer; Martin P J van Boxtel
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.